Poll
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Regulatory recap: FDA approvals in urology from the first half of 2025
Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB
FDA updates in urology: June 2025
Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB
FDA approves integrated sacral neuromodulation system for urinary urge incontinence
From prep to follow-up: Key considerations for administering onabotulinumtoxinA
UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC
Enrollment complete for phase 3 UTOPIA trial in LG-IR-NMIBC
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
FDA and EMA authorize phase 3 trial of masitinib for mCRPC